An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Clinical Outcome Assessment (COA) Qualification Program

DDT COA #000084: Kansas City Cardiomyopathy Questionnaire (KCCQ)

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Cardiology, Hematology, Endocrinology, and Nephrology (OCHEN)
Division of Cardiovascular and Nephrology (DCN)

DDT COA Number
DDT COA #000084

Instrument Name
Kansas City Cardiomyopathy Questionnaire (KCCQ)

Disease/Condition
Heart Failure (HF)

Concept of Interest
HF symptoms and their impact on physical limitations

Context of Use
Patients with HF

COA Type
PRO

Qualification Stage
Qualified

Requestor(s)
John Spertus

Contact(s)
John Spertus

Date Accepted into CDER’s COA Qualification Program
December 21, 2015

Qualification Date
April 9, 2020
Qualification Statement*

*Under review prior to the passage of the 21st Century Cures Act

Back to Clinical Outcome Assessments (COA) Qualification Submission

Top